COVID-19 Impact on Global Therapeutic Radioisotopes Market Insights, Forecast to 2026
Therapeutic Radioisotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Therapeutic Radioisotopes market is segmented into
The Therapeutic Radioisotopes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Therapeutic Radioisotopes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Therapeutic Radioisotopes Market Share Analysis
Therapeutic Radioisotopes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Radioisotopes business, the date to enter into the Therapeutic Radioisotopes market, Therapeutic Radioisotopes product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Therapeutic Radioisotopes market is segmented into
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
The Therapeutic Radioisotopes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Therapeutic Radioisotopes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Therapeutic Radioisotopes Market Share Analysis
Therapeutic Radioisotopes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Radioisotopes business, the date to enter into the Therapeutic Radioisotopes market, Therapeutic Radioisotopes product introduction, recent developments, etc.
The major vendors covered:
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Lantheus
- Spectrum Pharmaceuticals
- Progenics Pharmaceuticals
- International Isotopes
1 STUDY COVERAGE
1.1 Therapeutic Radioisotopes Product Introduction
1.2 Market Segments
1.3 Key Therapeutic Radioisotopes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type
1.4.2 Radium-223
1.4.3 Lutetium-177
1.4.4 Iodine-131
1.4.5 Other
1.5 Market by Application
1.5.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Radioisotopes Industry Impact
1.6.1 How the Covid-19 is Affecting the Therapeutic Radioisotopes Industry
1.6.1.1 Therapeutic Radioisotopes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Therapeutic Radioisotopes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Therapeutic Radioisotopes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts
2.1.1 Global Therapeutic Radioisotopes Revenue 2015-2026
2.1.2 Global Therapeutic Radioisotopes Sales 2015-2026
2.2 Therapeutic Radioisotopes Market Size by Region: 2020 Versus 2026
2.2.1 Global Therapeutic Radioisotopes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Therapeutic Radioisotopes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL THERAPEUTIC RADIOISOTOPES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Therapeutic Radioisotopes Sales by Manufacturers
3.1.1 Therapeutic Radioisotopes Sales by Manufacturers (2015-2020)
3.1.2 Therapeutic Radioisotopes Sales Market Share by Manufacturers (2015-2020)
3.2 Therapeutic Radioisotopes Revenue by Manufacturers
3.2.1 Therapeutic Radioisotopes Revenue by Manufacturers (2015-2020)
3.2.2 Therapeutic Radioisotopes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Therapeutic Radioisotopes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2019
3.2.5 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Therapeutic Radioisotopes Price by Manufacturers
3.4 Therapeutic Radioisotopes Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Radioisotopes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Radioisotopes Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Radioisotopes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Therapeutic Radioisotopes Market Size by Type (2015-2020)
4.1.1 Global Therapeutic Radioisotopes Sales by Type (2015-2020)
4.1.2 Global Therapeutic Radioisotopes Revenue by Type (2015-2020)
4.1.3 Therapeutic Radioisotopes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Therapeutic Radioisotopes Market Size Forecast by Type (2021-2026)
4.2.1 Global Therapeutic Radioisotopes Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2021-2026)
4.2.3 Therapeutic Radioisotopes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Therapeutic Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Therapeutic Radioisotopes Market Size by Application (2015-2020)
5.1.1 Global Therapeutic Radioisotopes Sales by Application (2015-2020)
5.1.2 Global Therapeutic Radioisotopes Revenue by Application (2015-2020)
5.1.3 Therapeutic Radioisotopes Price by Application (2015-2020)
5.2 Therapeutic Radioisotopes Market Size Forecast by Application (2021-2026)
5.2.1 Global Therapeutic Radioisotopes Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Radioisotopes Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Therapeutic Radioisotopes by Country
6.1.1 North America Therapeutic Radioisotopes Sales by Country
6.1.2 North America Therapeutic Radioisotopes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Therapeutic Radioisotopes Market Facts & Figures by Type
6.3 North America Therapeutic Radioisotopes Market Facts & Figures by Application
7 EUROPE
7.1 Europe Therapeutic Radioisotopes by Country
7.1.1 Europe Therapeutic Radioisotopes Sales by Country
7.1.2 Europe Therapeutic Radioisotopes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Radioisotopes Market Facts & Figures by Type
7.3 Europe Therapeutic Radioisotopes Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Therapeutic Radioisotopes by Region
8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Region
8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Type
8.3 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Therapeutic Radioisotopes by Country
9.1.1 Latin America Therapeutic Radioisotopes Sales by Country
9.1.2 Latin America Therapeutic Radioisotopes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Type
9.3 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Therapeutic Radioisotopes by Country
10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country
10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Type
10.3 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Therapeutic Radioisotopes Products Offered
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Therapeutic Radioisotopes Products Offered
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.3.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Products Offered
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Corporation Information
11.4.2 Dongcheng Description, Business Overview and Total Revenue
11.4.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dongcheng Therapeutic Radioisotopes Products Offered
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Corporation Information
11.5.2 Q BioMed Description, Business Overview and Total Revenue
11.5.3 Q BioMed Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Q BioMed Therapeutic Radioisotopes Products Offered
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Corporation Information
11.6.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Corporation Information
11.7.2 Jubilant DraxImage Description, Business Overview and Total Revenue
11.7.3 Jubilant DraxImage Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Products Offered
11.7.5 Jubilant DraxImage Recent Development
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Description, Business Overview and Total Revenue
11.8.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lantheus Therapeutic Radioisotopes Products Offered
11.8.5 Lantheus Recent Development
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Corporation Information
11.9.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.9.5 Spectrum Pharmaceuticals Recent Development
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.10.5 Progenics Pharmaceuticals Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Therapeutic Radioisotopes Products Offered
11.1.5 Bayer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Therapeutic Radioisotopes Market Estimates and Projections by Region
12.1.1 Global Therapeutic Radioisotopes Sales Forecast by Regions 2021-2026
12.1.2 Global Therapeutic Radioisotopes Revenue Forecast by Regions 2021-2026
12.2 North America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.2.1 North America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.2.2 North America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.2.3 North America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.3 Europe Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.3.1 Europe: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.3.2 Europe: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.3.3 Europe: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Therapeutic Radioisotopes Market Size Forecast by Region (2021-2026)
12.5 Latin America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.5.1 Latin America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.5.2 Latin America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.5.3 Latin America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Therapeutic Radioisotopes Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Therapeutic Radioisotopes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Therapeutic Radioisotopes Product Introduction
1.2 Market Segments
1.3 Key Therapeutic Radioisotopes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type
1.4.2 Radium-223
1.4.3 Lutetium-177
1.4.4 Iodine-131
1.4.5 Other
1.5 Market by Application
1.5.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application
1.5.2 Thyroid
1.5.3 Bone Metastasis
1.5.4 Lymphoma
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Radioisotopes Industry Impact
1.6.1 How the Covid-19 is Affecting the Therapeutic Radioisotopes Industry
1.6.1.1 Therapeutic Radioisotopes Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Therapeutic Radioisotopes Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Therapeutic Radioisotopes Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts
2.1.1 Global Therapeutic Radioisotopes Revenue 2015-2026
2.1.2 Global Therapeutic Radioisotopes Sales 2015-2026
2.2 Therapeutic Radioisotopes Market Size by Region: 2020 Versus 2026
2.2.1 Global Therapeutic Radioisotopes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Therapeutic Radioisotopes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL THERAPEUTIC RADIOISOTOPES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Therapeutic Radioisotopes Sales by Manufacturers
3.1.1 Therapeutic Radioisotopes Sales by Manufacturers (2015-2020)
3.1.2 Therapeutic Radioisotopes Sales Market Share by Manufacturers (2015-2020)
3.2 Therapeutic Radioisotopes Revenue by Manufacturers
3.2.1 Therapeutic Radioisotopes Revenue by Manufacturers (2015-2020)
3.2.2 Therapeutic Radioisotopes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Therapeutic Radioisotopes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2019
3.2.5 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Therapeutic Radioisotopes Price by Manufacturers
3.4 Therapeutic Radioisotopes Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Radioisotopes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Radioisotopes Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Radioisotopes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Therapeutic Radioisotopes Market Size by Type (2015-2020)
4.1.1 Global Therapeutic Radioisotopes Sales by Type (2015-2020)
4.1.2 Global Therapeutic Radioisotopes Revenue by Type (2015-2020)
4.1.3 Therapeutic Radioisotopes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Therapeutic Radioisotopes Market Size Forecast by Type (2021-2026)
4.2.1 Global Therapeutic Radioisotopes Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Type (2021-2026)
4.2.3 Therapeutic Radioisotopes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Therapeutic Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Therapeutic Radioisotopes Market Size by Application (2015-2020)
5.1.1 Global Therapeutic Radioisotopes Sales by Application (2015-2020)
5.1.2 Global Therapeutic Radioisotopes Revenue by Application (2015-2020)
5.1.3 Therapeutic Radioisotopes Price by Application (2015-2020)
5.2 Therapeutic Radioisotopes Market Size Forecast by Application (2021-2026)
5.2.1 Global Therapeutic Radioisotopes Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Radioisotopes Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Radioisotopes Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Therapeutic Radioisotopes by Country
6.1.1 North America Therapeutic Radioisotopes Sales by Country
6.1.2 North America Therapeutic Radioisotopes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Therapeutic Radioisotopes Market Facts & Figures by Type
6.3 North America Therapeutic Radioisotopes Market Facts & Figures by Application
7 EUROPE
7.1 Europe Therapeutic Radioisotopes by Country
7.1.1 Europe Therapeutic Radioisotopes Sales by Country
7.1.2 Europe Therapeutic Radioisotopes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Radioisotopes Market Facts & Figures by Type
7.3 Europe Therapeutic Radioisotopes Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Therapeutic Radioisotopes by Region
8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Region
8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Type
8.3 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Therapeutic Radioisotopes by Country
9.1.1 Latin America Therapeutic Radioisotopes Sales by Country
9.1.2 Latin America Therapeutic Radioisotopes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Type
9.3 Central & South America Therapeutic Radioisotopes Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Therapeutic Radioisotopes by Country
10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country
10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Type
10.3 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Therapeutic Radioisotopes Products Offered
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Therapeutic Radioisotopes Products Offered
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Description, Business Overview and Total Revenue
11.3.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Products Offered
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Corporation Information
11.4.2 Dongcheng Description, Business Overview and Total Revenue
11.4.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Dongcheng Therapeutic Radioisotopes Products Offered
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Corporation Information
11.5.2 Q BioMed Description, Business Overview and Total Revenue
11.5.3 Q BioMed Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Q BioMed Therapeutic Radioisotopes Products Offered
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Corporation Information
11.6.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Corporation Information
11.7.2 Jubilant DraxImage Description, Business Overview and Total Revenue
11.7.3 Jubilant DraxImage Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Products Offered
11.7.5 Jubilant DraxImage Recent Development
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Description, Business Overview and Total Revenue
11.8.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lantheus Therapeutic Radioisotopes Products Offered
11.8.5 Lantheus Recent Development
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Corporation Information
11.9.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.9.5 Spectrum Pharmaceuticals Recent Development
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Products Offered
11.10.5 Progenics Pharmaceuticals Recent Development
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description, Business Overview and Total Revenue
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Therapeutic Radioisotopes Products Offered
11.1.5 Bayer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Therapeutic Radioisotopes Market Estimates and Projections by Region
12.1.1 Global Therapeutic Radioisotopes Sales Forecast by Regions 2021-2026
12.1.2 Global Therapeutic Radioisotopes Revenue Forecast by Regions 2021-2026
12.2 North America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.2.1 North America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.2.2 North America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.2.3 North America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.3 Europe Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.3.1 Europe: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.3.2 Europe: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.3.3 Europe: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Therapeutic Radioisotopes Market Size Forecast by Region (2021-2026)
12.5 Latin America Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.5.1 Latin America: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.5.2 Latin America: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.5.3 Latin America: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Therapeutic Radioisotopes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Therapeutic Radioisotopes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Therapeutic Radioisotopes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Therapeutic Radioisotopes Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Therapeutic Radioisotopes Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Therapeutic Radioisotopes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Therapeutic Radioisotopes Market Segments
Table 2. Ranking of Global Top Therapeutic Radioisotopes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Therapeutic Radioisotopes Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Lutetium-177
Table 6. Major Manufacturers of Iodine-131
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Therapeutic Radioisotopes Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Therapeutic Radioisotopes Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Therapeutic Radioisotopes Players to Combat Covid-19 Impact
Table 13. Global Therapeutic Radioisotopes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Therapeutic Radioisotopes Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Therapeutic Radioisotopes Sales by Regions 2015-2020 (K Units)
Table 16. Global Therapeutic Radioisotopes Sales Market Share by Regions (2015-2020)
Table 17. Global Therapeutic Radioisotopes Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Therapeutic Radioisotopes Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Therapeutic Radioisotopes Sales Share by Manufacturers (2015-2020)
Table 20. Global Therapeutic Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Radioisotopes as of 2019)
Table 22. Therapeutic Radioisotopes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Therapeutic Radioisotopes Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Therapeutic Radioisotopes Price (2015-2020) (USD/Unit)
Table 25. Therapeutic Radioisotopes Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Therapeutic Radioisotopes Product Type
Table 27. Date of International Manufacturers Enter into Therapeutic Radioisotopes Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 30. Global Therapeutic Radioisotopes Sales Share by Type (2015-2020)
Table 31. Global Therapeutic Radioisotopes Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Therapeutic Radioisotopes Revenue Share by Type (2015-2020)
Table 33. Therapeutic Radioisotopes Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 35. Global Therapeutic Radioisotopes Sales Share by Application (2015-2020)
Table 36. North America Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 37. North America Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 38. North America Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 40. North America Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 41. North America Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 42. North America Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 43. North America Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 44. Europe Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 45. Europe Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 46. Europe Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 48. Europe Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 49. Europe Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 50. Europe Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 51. Europe Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Therapeutic Radioisotopes Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 60. Latin America Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 61. Latin America Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 64. Latin America Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 65. Latin America Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 66. Latin America Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 67. Latin America Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 76. Bayer Corporation Information
Table 77. Bayer Description and Major Businesses
Table 78. Bayer Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Bayer Product
Table 80. Bayer Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. China Isotope & Radiation Corporation Information
Table 87. China Isotope & Radiation Description and Major Businesses
Table 88. China Isotope & Radiation Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. China Isotope & Radiation Product
Table 90. China Isotope & Radiation Recent Development
Table 91. Dongcheng Corporation Information
Table 92. Dongcheng Description and Major Businesses
Table 93. Dongcheng Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Dongcheng Product
Table 95. Dongcheng Recent Development
Table 96. Q BioMed Corporation Information
Table 97. Q BioMed Description and Major Businesses
Table 98. Q BioMed Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Q BioMed Product
Table 100. Q BioMed Recent Development
Table 101. Curium Pharmaceuticals Corporation Information
Table 102. Curium Pharmaceuticals Description and Major Businesses
Table 103. Curium Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Curium Pharmaceuticals Product
Table 105. Curium Pharmaceuticals Recent Development
Table 106. Jubilant DraxImage Corporation Information
Table 107. Jubilant DraxImage Description and Major Businesses
Table 108. Jubilant DraxImage Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Jubilant DraxImage Product
Table 110. Jubilant DraxImage Recent Development
Table 111. Lantheus Corporation Information
Table 112. Lantheus Description and Major Businesses
Table 113. Lantheus Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Lantheus Product
Table 115. Lantheus Recent Development
Table 116. Spectrum Pharmaceuticals Corporation Information
Table 117. Spectrum Pharmaceuticals Description and Major Businesses
Table 118. Spectrum Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Spectrum Pharmaceuticals Product
Table 120. Spectrum Pharmaceuticals Recent Development
Table 121. Progenics Pharmaceuticals Corporation Information
Table 122. Progenics Pharmaceuticals Description and Major Businesses
Table 123. Progenics Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Progenics Pharmaceuticals Product
Table 125. Progenics Pharmaceuticals Recent Development
Table 126. International Isotopes Corporation Information
Table 127. International Isotopes Description and Major Businesses
Table 128. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. International Isotopes Product
Table 130. International Isotopes Recent Development
Table 131. Global Therapeutic Radioisotopes Sales Forecast by Regions (2021-2026) (K Units)
Table 132. Global Therapeutic Radioisotopes Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Therapeutic Radioisotopes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 136. North America: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 138. Europe: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Therapeutic Radioisotopes Sales Forecast by Region (2021-2026) (K Units)
Table 140. Asia Pacific: Therapeutic Radioisotopes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 142. Latin America: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 144. Middle East and Africa: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Therapeutic Radioisotopes Players
Table 149. Therapeutic Radioisotopes Customers List
Table 150. Therapeutic Radioisotopes Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Therapeutic Radioisotopes Market Segments
Table 2. Ranking of Global Top Therapeutic Radioisotopes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Therapeutic Radioisotopes Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Lutetium-177
Table 6. Major Manufacturers of Iodine-131
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Therapeutic Radioisotopes Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Therapeutic Radioisotopes Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Therapeutic Radioisotopes Players to Combat Covid-19 Impact
Table 13. Global Therapeutic Radioisotopes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Therapeutic Radioisotopes Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Therapeutic Radioisotopes Sales by Regions 2015-2020 (K Units)
Table 16. Global Therapeutic Radioisotopes Sales Market Share by Regions (2015-2020)
Table 17. Global Therapeutic Radioisotopes Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Therapeutic Radioisotopes Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Therapeutic Radioisotopes Sales Share by Manufacturers (2015-2020)
Table 20. Global Therapeutic Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Radioisotopes as of 2019)
Table 22. Therapeutic Radioisotopes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Therapeutic Radioisotopes Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Therapeutic Radioisotopes Price (2015-2020) (USD/Unit)
Table 25. Therapeutic Radioisotopes Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Therapeutic Radioisotopes Product Type
Table 27. Date of International Manufacturers Enter into Therapeutic Radioisotopes Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 30. Global Therapeutic Radioisotopes Sales Share by Type (2015-2020)
Table 31. Global Therapeutic Radioisotopes Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Therapeutic Radioisotopes Revenue Share by Type (2015-2020)
Table 33. Therapeutic Radioisotopes Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 35. Global Therapeutic Radioisotopes Sales Share by Application (2015-2020)
Table 36. North America Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 37. North America Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 38. North America Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 40. North America Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 41. North America Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 42. North America Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 43. North America Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 44. Europe Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 45. Europe Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 46. Europe Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 48. Europe Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 49. Europe Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 50. Europe Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 51. Europe Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Therapeutic Radioisotopes Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 60. Latin America Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 61. Latin America Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 64. Latin America Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 65. Latin America Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 66. Latin America Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 67. Latin America Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Table 76. Bayer Corporation Information
Table 77. Bayer Description and Major Businesses
Table 78. Bayer Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Bayer Product
Table 80. Bayer Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. China Isotope & Radiation Corporation Information
Table 87. China Isotope & Radiation Description and Major Businesses
Table 88. China Isotope & Radiation Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. China Isotope & Radiation Product
Table 90. China Isotope & Radiation Recent Development
Table 91. Dongcheng Corporation Information
Table 92. Dongcheng Description and Major Businesses
Table 93. Dongcheng Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Dongcheng Product
Table 95. Dongcheng Recent Development
Table 96. Q BioMed Corporation Information
Table 97. Q BioMed Description and Major Businesses
Table 98. Q BioMed Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Q BioMed Product
Table 100. Q BioMed Recent Development
Table 101. Curium Pharmaceuticals Corporation Information
Table 102. Curium Pharmaceuticals Description and Major Businesses
Table 103. Curium Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Curium Pharmaceuticals Product
Table 105. Curium Pharmaceuticals Recent Development
Table 106. Jubilant DraxImage Corporation Information
Table 107. Jubilant DraxImage Description and Major Businesses
Table 108. Jubilant DraxImage Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Jubilant DraxImage Product
Table 110. Jubilant DraxImage Recent Development
Table 111. Lantheus Corporation Information
Table 112. Lantheus Description and Major Businesses
Table 113. Lantheus Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Lantheus Product
Table 115. Lantheus Recent Development
Table 116. Spectrum Pharmaceuticals Corporation Information
Table 117. Spectrum Pharmaceuticals Description and Major Businesses
Table 118. Spectrum Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Spectrum Pharmaceuticals Product
Table 120. Spectrum Pharmaceuticals Recent Development
Table 121. Progenics Pharmaceuticals Corporation Information
Table 122. Progenics Pharmaceuticals Description and Major Businesses
Table 123. Progenics Pharmaceuticals Therapeutic Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Progenics Pharmaceuticals Product
Table 125. Progenics Pharmaceuticals Recent Development
Table 126. International Isotopes Corporation Information
Table 127. International Isotopes Description and Major Businesses
Table 128. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. International Isotopes Product
Table 130. International Isotopes Recent Development
Table 131. Global Therapeutic Radioisotopes Sales Forecast by Regions (2021-2026) (K Units)
Table 132. Global Therapeutic Radioisotopes Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Therapeutic Radioisotopes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 136. North America: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 138. Europe: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Therapeutic Radioisotopes Sales Forecast by Region (2021-2026) (K Units)
Table 140. Asia Pacific: Therapeutic Radioisotopes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 142. Latin America: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Therapeutic Radioisotopes Sales Forecast by Country (2021-2026) (K Units)
Table 144. Middle East and Africa: Therapeutic Radioisotopes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Therapeutic Radioisotopes Players
Table 149. Therapeutic Radioisotopes Customers List
Table 150. Therapeutic Radioisotopes Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Therapeutic Radioisotopes Product Picture
Figure 2. Global Therapeutic Radioisotopes Sales Market Share by Type in 2020 & 2026
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Radioisotopes Sales Market Share by Application in 2020 & 2026
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Radioisotopes Report Years Considered
Figure 13. Global Therapeutic Radioisotopes Market Size 2015-2026 (US$ Million)
Figure 14. Global Therapeutic Radioisotopes Sales 2015-2026 (K Units)
Figure 15. Global Therapeutic Radioisotopes Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Therapeutic Radioisotopes Sales Market Share by Region (2015-2020)
Figure 17. Global Therapeutic Radioisotopes Sales Market Share by Region in 2019
Figure 18. Global Therapeutic Radioisotopes Revenue Market Share by Region (2015-2020)
Figure 19. Global Therapeutic Radioisotopes Revenue Market Share by Region in 2019
Figure 20. Global Therapeutic Radioisotopes Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Therapeutic Radioisotopes Revenue in 2019
Figure 22. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Figure 24. Global Therapeutic Radioisotopes Sales Market Share by Type in 2019
Figure 25. Global Therapeutic Radioisotopes Revenue Market Share by Type (2015-2020)
Figure 26. Global Therapeutic Radioisotopes Revenue Market Share by Type in 2019
Figure 27. Global Therapeutic Radioisotopes Market Share by Price Range (2015-2020)
Figure 28. Global Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Figure 29. Global Therapeutic Radioisotopes Sales Market Share by Application in 2019
Figure 30. Global Therapeutic Radioisotopes Revenue Market Share by Application (2015-2020)
Figure 31. Global Therapeutic Radioisotopes Revenue Market Share by Application in 2019
Figure 32. North America Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 35. North America Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 36. U.S. Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Therapeutic Radioisotopes Market Share by Type in 2019
Figure 41. North America Therapeutic Radioisotopes Market Share by Application in 2019
Figure 42. Europe Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 45. Europe Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 46. Germany Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Therapeutic Radioisotopes Market Share by Type in 2019
Figure 57. Europe Therapeutic Radioisotopes Market Share by Application in 2019
Figure 58. Asia Pacific Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region in 2019
Figure 61. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region in 2019
Figure 62. China Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Therapeutic Radioisotopes Market Share by Type in 2019
Figure 85. Asia Pacific Therapeutic Radioisotopes Market Share by Application in 2019
Figure 86. Latin America Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 89. Latin America Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 90. Mexico Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Therapeutic Radioisotopes Market Share by Type in 2019
Figure 97. Latin America Therapeutic Radioisotopes Market Share by Application in 2019
Figure 98. Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 102. Turkey Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Therapeutic Radioisotopes Market Share by Type in 2019
Figure 109. Middle East and Africa Therapeutic Radioisotopes Market Share by Application in 2019
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Q BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant DraxImage Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Progenics Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. International Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. North America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Europe Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Asia Pacific Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Latin America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Middle East and Africa Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Figure 1. Therapeutic Radioisotopes Product Picture
Figure 2. Global Therapeutic Radioisotopes Sales Market Share by Type in 2020 & 2026
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Radioisotopes Sales Market Share by Application in 2020 & 2026
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Radioisotopes Report Years Considered
Figure 13. Global Therapeutic Radioisotopes Market Size 2015-2026 (US$ Million)
Figure 14. Global Therapeutic Radioisotopes Sales 2015-2026 (K Units)
Figure 15. Global Therapeutic Radioisotopes Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Therapeutic Radioisotopes Sales Market Share by Region (2015-2020)
Figure 17. Global Therapeutic Radioisotopes Sales Market Share by Region in 2019
Figure 18. Global Therapeutic Radioisotopes Revenue Market Share by Region (2015-2020)
Figure 19. Global Therapeutic Radioisotopes Revenue Market Share by Region in 2019
Figure 20. Global Therapeutic Radioisotopes Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Therapeutic Radioisotopes Revenue in 2019
Figure 22. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Therapeutic Radioisotopes Sales Market Share by Type (2015-2020)
Figure 24. Global Therapeutic Radioisotopes Sales Market Share by Type in 2019
Figure 25. Global Therapeutic Radioisotopes Revenue Market Share by Type (2015-2020)
Figure 26. Global Therapeutic Radioisotopes Revenue Market Share by Type in 2019
Figure 27. Global Therapeutic Radioisotopes Market Share by Price Range (2015-2020)
Figure 28. Global Therapeutic Radioisotopes Sales Market Share by Application (2015-2020)
Figure 29. Global Therapeutic Radioisotopes Sales Market Share by Application in 2019
Figure 30. Global Therapeutic Radioisotopes Revenue Market Share by Application (2015-2020)
Figure 31. Global Therapeutic Radioisotopes Revenue Market Share by Application in 2019
Figure 32. North America Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 35. North America Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 36. U.S. Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Therapeutic Radioisotopes Market Share by Type in 2019
Figure 41. North America Therapeutic Radioisotopes Market Share by Application in 2019
Figure 42. Europe Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 45. Europe Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 46. Germany Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Therapeutic Radioisotopes Market Share by Type in 2019
Figure 57. Europe Therapeutic Radioisotopes Market Share by Application in 2019
Figure 58. Asia Pacific Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Region in 2019
Figure 61. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Region in 2019
Figure 62. China Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Therapeutic Radioisotopes Market Share by Type in 2019
Figure 85. Asia Pacific Therapeutic Radioisotopes Market Share by Application in 2019
Figure 86. Latin America Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 89. Latin America Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 90. Mexico Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Therapeutic Radioisotopes Market Share by Type in 2019
Figure 97. Latin America Therapeutic Radioisotopes Market Share by Application in 2019
Figure 98. Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Therapeutic Radioisotopes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Country in 2019
Figure 102. Turkey Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Therapeutic Radioisotopes Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Therapeutic Radioisotopes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Therapeutic Radioisotopes Market Share by Type in 2019
Figure 109. Middle East and Africa Therapeutic Radioisotopes Market Share by Application in 2019
Figure 110. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Q BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Jubilant DraxImage Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Progenics Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. International Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. North America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Europe Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Asia Pacific Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Latin America Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Middle East and Africa Therapeutic Radioisotopes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
